PURPOSE: The aim of this study was to demonstrate the effectiveness of interventional techniques in the palliative management of painful extraspinal bone metastases. MATERIALS AND METHODS: Cementoplasty alone or in combination with radiofrequency (RF) ablation was performed in 14 skeletal extravertebral segments in 13 patients with ages ranging from 50 to 74 (average 67) years. The primary tumours were myeloma (n=5), renal carcinoma (n=5), hepatocellular carcinoma (n=2) and bladder carcinoma (n=2). Metastases were located at the acetabulum (n=4), femur (n=5), humerus (n=1), scapula (n=2) and iliac bone (n=2). The clinical indication was a pain intensity score >4 on the visual analogue scale (VAS) partially or totally refractory to analgesic medication. Clinical evaluation was based on clinical and neurological conditions before and immediately after the procedure and during the follow-up. RESULTS: Technical success was achieved in all cases. Ten patients were treated by cementoplasty alone and four cases by cementoplasty combined with RF ablation. After treatment, all patients experienced improved symptoms, as demonstrated by the VAS score, which remained constant during follow-up. All patients were followed for between 2 and 14 (average 6.1) months. We had one major complication in a patient who developed an abscess, which was treated by percutaneous drainage. CONCLUSIONS: In our experience, cementoplasty alone for small lesions or combined with RF ablation in larger lesions is an effective and safe therapy in the palliative management of painful extraspinal bone metastases.
PURPOSE: The aim of this study was to demonstrate the effectiveness of interventional techniques in the palliative management of painful extraspinal bone metastases. MATERIALS AND METHODS: Cementoplasty alone or in combination with radiofrequency (RF) ablation was performed in 14 skeletal extravertebral segments in 13 patients with ages ranging from 50 to 74 (average 67) years. The primary tumours were myeloma (n=5), renal carcinoma (n=5), hepatocellular carcinoma (n=2) and bladder carcinoma (n=2). Metastases were located at the acetabulum (n=4), femur (n=5), humerus (n=1), scapula (n=2) and iliac bone (n=2). The clinical indication was a pain intensity score >4 on the visual analogue scale (VAS) partially or totally refractory to analgesic medication. Clinical evaluation was based on clinical and neurological conditions before and immediately after the procedure and during the follow-up. RESULTS: Technical success was achieved in all cases. Ten patients were treated by cementoplasty alone and four cases by cementoplasty combined with RF ablation. After treatment, all patients experienced improved symptoms, as demonstrated by the VAS score, which remained constant during follow-up. All patients were followed for between 2 and 14 (average 6.1) months. We had one major complication in a patient who developed an abscess, which was treated by percutaneous drainage. CONCLUSIONS: In our experience, cementoplasty alone for small lesions or combined with RF ablation in larger lesions is an effective and safe therapy in the palliative management of painful extraspinal bone metastases.
Authors: P Y Marcy; J Palussière; B Descamps; N Magné; P Y Bondiau; C Ciais; J N Bruneton Journal: Support Care Cancer Date: 2000-11 Impact factor: 3.603
Authors: Oliver Schaefer; Christian Lohrmann; Max Markmiller; Peter Uhrmeister; Mathias Langer Journal: AJR Am J Roentgenol Date: 2003-04 Impact factor: 3.959
Authors: B Kastler; M Jacamon; S Aubry; F G Barral; G Hadjidekov; P Sarliève; O Saguet; J M Lerais; G Cadel; R Kovacs; H Boulahdour; P Pereira Journal: J Radiol Date: 2007-09
Authors: Matthew P Goetz; Matthew R Callstrom; J William Charboneau; Michael A Farrell; Timothy P Maus; Timothy J Welch; Gilbert Y Wong; Jeff A Sloan; Paul J Novotny; Ivy A Petersen; Robert A Beres; Daniele Regge; Rodolfo Capanna; Mark B Saker; Dietrich H W Grönemeyer; Athour Gevargez; Kamran Ahrar; Michael A Choti; Thierry J de Baere; Joseph Rubin Journal: J Clin Oncol Date: 2004-01-15 Impact factor: 44.544
Authors: Matthew R Callstrom; J William Charboneau; Matthew P Goetz; Joseph Rubin; Gilbert Y Wong; Jeff A Sloan; Paul J Novotny; Bradley D Lewis; Timothy J Welch; Michael A Farrell; Timothy P Maus; Robert A Lee; Carl C Reading; Ivy A Petersen; Deitra D Pickett Journal: Radiology Date: 2002-07 Impact factor: 11.105
Authors: A Cotten; F Dewatre; B Cortet; R Assaker; D Leblond; B Duquesnoy; P Chastanet; J Clarisse Journal: Radiology Date: 1996-08 Impact factor: 11.105
Authors: Salvatore Masala; Tommaso Volpi; Francesco P M Fucci; Maria Cantonetti; Massimiliano Postorino; Giovanni Simonetti Journal: Support Care Cancer Date: 2010-05-27 Impact factor: 3.603
Authors: Michael David Lane; Huy B Q Le; Steven Lee; Casey Young; Manraj K S Heran; Maziar Badii; Paul William Clarkson; Peter L Munk Journal: Skeletal Radiol Date: 2010-08-05 Impact factor: 2.199
Authors: Antonio Basile; Salvatore Masala; Giuseppe Banna; Elisa Cotta; Maide Cavalli; Paolo Fiumara; Francesco Di Raimondo; Elena Mundo; Giovanni Scavone; Antonio Granata; Gianpaolo Carrafiello; Dimitrios Tsetis Journal: Skeletal Radiol Date: 2011-11-16 Impact factor: 2.199
Authors: G Carrafiello; D Laganà; C Pellegrino; F Fontana; M Mangini; P Nicotera; M Petullà; E Bracchi; E Genovese; S Cuffari; C Fugazzola Journal: Radiol Med Date: 2009-05-14 Impact factor: 3.469
Authors: Allan Lipton; Robert Uzzo; Robert J Amato; Georgiana K Ellis; Behrooz Hakimian; G David Roodman; Matthew R Smith Journal: J Natl Compr Canc Netw Date: 2009-10 Impact factor: 11.908